The development of drotrecogin alfa (activated) for the treatment of severe sepsis

Int J Artif Organs. 2004 May;27(5):360-70. doi: 10.1177/039139880402700504.
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Infective Agents / pharmacology
  • Anti-Infective Agents / therapeutic use*
  • Clinical Trials as Topic
  • Humans
  • Immunity, Innate / drug effects*
  • Immunity, Innate / immunology
  • Protein C / immunology*
  • Protein C / pharmacology
  • Protein C / therapeutic use*
  • Recombinant Proteins / pharmacology
  • Recombinant Proteins / therapeutic use*
  • Sepsis / drug therapy*

Substances

  • Anti-Infective Agents
  • Protein C
  • Recombinant Proteins
  • drotrecogin alfa activated